Clinical Trial

Effectiveness of Medium-Dose Cytarabine Combined With Venetoclax for Consolidation Therapy in Elderly Patients With Intermediate to High-Risk Acute Myeloid Leukemia

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
A Single-center, Single-arm, Prospective Clinical Study of Intermediate-dose Cytarabine in Combination with Venetoclax for Consolidation Therapy of Middle- and High-risk Acute Myeloid Leukemia in the Elderly
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-23.
Status change: Not Yet Recruiting → Recruiting 2025-08-05
Trial Details
NCT Number NCT06990321
Lead Sponsor Yehui Tan
Conditions Acute Myeloid Leukemia (AML), Elderly
Enrollment 68 participants
Start Date 2025-06-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-08